We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$172M
AUM Growth
+$31.4M
Cap. Flow
+$6.81M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.07%
Holding
144
New
12
Increased
10
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.52M
2
NKE icon
Nike
NKE
+$1.55M
3
IRM icon
Iron Mountain
IRM
+$1.14M
4
AMZN icon
Amazon
AMZN
+$725K
5
ABBV icon
AbbVie
ABBV
+$337K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.61M
2
AGO icon
Assured Guaranty
AGO
+$1.43M
3
CLF icon
Cleveland-Cliffs
CLF
+$199K
4
AYTU icon
AYTU BioPharma
AYTU
+$199K
5
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$166K

Sector Composition

Rank Sector Weight
1 Healthcare 21.93%
2 Technology 18.94%
3 Industrials 10.96%
4 Financials 10.71%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
101
Medtronic
MDT
$106B
$295K 0.17%
3,219
– –
UNP icon
102
Union Pacific
UNP
$179B
$293K 0.17%
1,733
– –
TMO icon
103
Thermo Fisher Scientific
TMO
$198B
$292K 0.17%
805
– –
SONY icon
104
Sony
SONY
$124B
$290K 0.17%
21,000
– –
DGX icon
105
Quest Diagnostics
DGX
$23.3B
$285K 0.17%
2,500
– –
EOG icon
106
EOG Resources
EOG
$74.5B
$284K 0.16%
5,600
– –
EMR icon
107
Emerson Electric
EMR
$78.2B
$280K 0.16%
4,510
– –
GLD icon
108
SPDR Gold Trust
GLD
$130B
$275K 0.16%
1,646
– –
COP icon
109
ConocoPhillips
COP
$140B
$268K 0.16%
+6,383
New +$258K
SEE
110
DELISTED
Sealed Air
SEE
$265K 0.15%
+8,070
New +$242K
F icon
111
Ford
F
$56.7B
$262K 0.15%
43,100
– –
EFA icon
112
iShares MSCI EAFE ETF
EFA
$76.5B
$260K 0.15%
4,269
– –
CMCSA icon
113
Comcast
CMCSA
$85B
$258K 0.15%
6,608
– –
TSLA icon
114
Tesla
TSLA
$1.43T
$248K 0.14%
+3,450
New +$187K
GE icon
115
GE Aerospace
GE
$364B
$237K 0.14%
6,969
-97
-1% -$3.27K
CDK
116
DELISTED
CDK Global, Inc.
CDK
$236K 0.14%
+5,700
New +$219K
RTX icon
117
RTX Corp
RTX
$261B
$231K 0.13%
+3,748
New +$234K
BNY
118
Bank of New York Mellon
BNY
$108B
$220K 0.13%
+5,683
New +$208K
KMB icon
119
Kimberly-Clark
KMB
$36B
$219K 0.13%
+1,550
New +$214K
TRGP icon
120
Targa Resources
TRGP
$60.7B
$211K 0.12%
10,500
-145
-1% -$2.18K
CQP icon
121
Cheniere Energy
CQP
$30.2B
$210K 0.12%
+6,000
New +$201K
EEM icon
122
iShares MSCI Emerging Markets ETF
EEM
$28B
$200K 0.12%
5,000
-1,500
-23% -$56.1K
LOW icon
123
Lowe's Companies
LOW
$117B
$200K 0.12%
+1,482
New +$169K
GCP
124
DELISTED
GCP Applied Technologies Inc.
GCP
$196K 0.11%
10,550
– –
IAU icon
125
iShares Gold Trust
IAU
$62.4B
$170K 0.1%
+5,000
New +$164K
2 3 4
5
6

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Searle & Co held 144 positions worth $172M, up 22% from $141M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Searle & Co deployed $6.81M of net new capital in Q2 2020, opening 12 new positions and adding to 10 existing holdings. Its largest new stake was Nike: 16,795 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AYTU BioPharma, an estimated $199K trimmed.

  • Searle & Co's largest Q2 2020 buy was Nike: 16,795 shares worth $1.65M.
  • Searle & Co added most to Apple in Q2 2020, an estimated $4.52M increase.
  • Searle & Co's biggest Q2 2020 reduction was AYTU BioPharma, cutting an estimated $199K.
  • Searle & Co fully exited Allergan plc in Q2 2020, selling an estimated $1.61M.
  • Searle & Co's ten largest holdings make up 31% of its $172M portfolio in Q2 2020.
  • Searle & Co opened 12 new positions and closed 4 in Q2 2020.
  • Searle & Co's portfolio value rose 22% quarter-over-quarter to $172M.

Based on Searle & Co's 13F filing for Q2 2020, filed 3 Aug 2020.